Menu REIMBURSEMENT SUPPORT AND PATIENT ASSISTANCE PROGRAMS Need help paying for your Merck products? At Merck, we believe that no one should go without the medicines or vaccines they need. Reimbursement Support Patient Assistance Program &lt;p&gt;Your browser does not support iframes.&lt;/p&gt; RELATED INFORMATION Annual Reports Company Fact Sheet Copyright. © 2009-2017 Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc. All rights reserved. Forward-Looking Statement Privacy Terms of Use Site Map

Menu WHY DRUG DISCOVERY IS THE FOUNDATION OF MERCK'S FUTURE Our discovery scientists “strive to make the impossible possible,” says Joe Miletich. And he should know: As the senior vice president of Discovery Preclinical and Early Development, he leads a team of researchers who are charged with making things “possible that weren’t possible before.” He continues: “At Merck, we believe drug discovery is foundational for us to continue bringing critical medicines to the world.” About 12,000 people are involved in scientific research at Merck. Our U.S. R&D colleagues are located across the country — from Massachusetts to New Jersey to Pennsylvania to California — but they are all tasked with the same mission: to solve the puzzles of human disease biology and then translate those findings into new therapies for patients. They are driven to push the boundaries of science and to then transform their discoveries into meaningful new therapeutics. We're inspired to invent medicines and vaccines to help address the health challenges faced by so many. “I think we always have a sense of urgency,” says Daria Hazuda, vice president of Infectious Diseases and Vaccines Discovery, and chief scientific officer of our recently launched Cambridge Exploratory Science Center. “We’re always driven to push the envelope, to push the frontier, to do something that nobody’s ever done before.” MEET DARIA HAZUDA “The ‘inspiration to invent’ remains our driving passion – and a proven path to dramatic advances in human health.” — Ken Frazier, Merck chairman and CEO Our teams never shy away from the hard work and many years it takes to invent a molecule with the potential to change the course of a disease - and a person's life. And that’s one reason why a commitment to unparalleled scientific research – to discovery and invention – remains at the heart of our business. Commitment to Research ~12,000 people are involved in Merck R&D. They share a commitment to turn breakthrough science into meaningful therapeutic options for patients. We continue to invest in discovery because the world needs cures. We see it as our responsibility to invent solutions that fundamentally transform the future of human health. Watch the video to learn more about what drives our discovery researchers. Published March 2017 Copyright. © 2009-2017 Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc. All rights reserved. Forward-Looking Statement Privacy Terms of Use Site Map